SiMPore Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $225K
Latest Deal Amount
  • Investors
  • 6

SiMPore General Information

Description

Developer of nanotechnology designed to offer silicon-based precision membranes for biomedical and material science applications. The company's products include filters for separating and concentrating biological molecules and nanoparticles, cell culture substrates for growing cells, and electron microscopy grids for preparing and imaging samples at the nanoscale, enabling clients to do imaging and analysis of nanoscale materials easily.

Contact Information

Website
www.simpore.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 150 Lucius Gordon Drive
  • Suite 119
  • West Henrietta, NY 14586
  • United States
+1 (888) 000-0000

SiMPore Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SiMPore Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Jan-2019 $225K 00.000 Completed Generating Revenue
5. Grant 01-Jan-2018 00000 00.000 Completed Generating Revenue
4. Grant 01-Aug-2017 00.000 00.000 Completed Generating Revenue
3. Accelerator/Incubator 15-Dec-2010 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 16-Jun-2010 $1M $2.25M 00.00 Completed Generating Revenue
1. Early Stage VC 30-May-2008 $1.25M $1.25M Completed Generating Revenue
To view SiMPore’s complete valuation and funding history, request access »

SiMPore Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000 00.000000 00 000 000 00 000 00.000
To view SiMPore’s complete cap table history, request access »

SiMPore Executive Team (5)

Name Title Board Seat Contact Info
Philippe Fauchet Ph.D Co-Founder & Co-Owner
James Roussie Ph.D Co-Founder, Chief Scientific Officer & Vice President, Operations
James McGrath Ph.D Co-Founder & Technical Advisor
Thomas Gaborski Ph.D Co-Founder & Technical Advisor
Christopher Striemer Ph.D Co-Founder, Technical Advisor & Vice President, Membrane Development
To view SiMPore’s complete executive team members history, request access »

SiMPore Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SiMPore Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
NextCorps Accelerator/Incubator 000 0000 000000 0
Rochester Angel Network Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »